Podcast

Pharmacy Focus: Psychedelic Pharmacy - The Future of Ketamine

Industry partnerships will be essential to improving access to ketamine, according to expert Kevin Nicholson.

This month, we spoke with Kevin Nicholson, CEO of Ketamine Wellness Centers and recently-announced CEO of Delic Corp., to discuss the future of ketamine research and why industry partnerships will be crucial to improving access.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Menoapuse spelled with wooden blocks -- Image credit: loran4a | stock.adobe.com
Related Content
Image credit: David A Litman | stock.adobe.com
June 11th 2025

Taletrectinib Gains FDA Approval for Locally Advanced or Metastatic ROS1+ NSCLC

Gillian McGovern, Associate Editor
S2. Ep 56: Insights From a Pharmacy Times Peer Exchange: How to Talk the Talk
June 3rd 2025

S2. Ep 56: Insights From a Pharmacy Times Peer Exchange: How to Talk the Talk

Alexandra Gerlach, Associate Editor
Community Pharmacist Collaboration Expands Access to Long-Acting Injectable Antipsychotics
June 9th 2025

Community Pharmacist Collaboration Expands Access to Long-Acting Injectable Antipsychotics

Aislinn Antrim, Managing Editor
New Programs Aim to Improve Implementation of Cardiovascular Interventions
June 3rd 2025

New Programs Aim to Improve Implementation of Cardiovascular Interventions

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
Burned out pharmacy resident -- Image credit: Anela Ramba/peopleimages.com | stock.adobe.com
June 6th 2025

Resident Mental Health Matters

Brianne Perry, PharmD
Health care professional assessing x-ray scan of brain -- Image credit: New Africa | stock.adobe.com
May 28th 2025

Integrated Outpatient Specialty Neurology Pharmacists Influence Care in Non-MS Clinical Settings

Kayla Johnson, PharmD, BCPS, BCPP